SCHEMBL7673584

SCHEMBL7673584

O=C(NC(Cc1ccccc1-c1ccccc1)c1cccnc1)c1cccc2c1OCO2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA5 P22460 5/20 0.48
▸ KCNH2 Q12809 2/20 0.48
▸ KMT2A Q03164 3/20 0.39
▸ HTT P42858 1/20 0.39
▸ SUCNR1 Q9BXA5 2/20 0.39
▸ DHPS P49366 1/20 0.39
▸ ADRB1 P08588 1/20 0.39
▸ ADRB3 P13945 1/20 0.39
▸ TACR3 P29371 1/20 0.38
▸ ITGA4 P13612 1/20 0.38
▸ ROCK2 O75116 2/20 0.37
▸ EED O75530 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6779728 0.80 KCNA5 (0.53) KCNA5KCNH2KMT2AHTTSUCNR1
SCHEMBL6779481 0.72 KCNA5 (0.50) KCNA5KCNH2DHPS
SCHEMBL7673590 0.72 ALDH1A1 (0.46) KCNA5KMT2AHTTMEN1ALDH1A1
SCHEMBL6779237 0.71 RXFP1 (0.50) KCNA5KCNH2KMT2AHTTSUCNR1
SCHEMBL2062779 0.68 KCNA5 (1.00) KCNA5KCNH2KMT2ATSHRMAPK1
SCHEMBL6773913 0.67 LTB4R2 (0.41) ROCK2EEDALDH1A1
SCHEMBL2063707 0.67 KCNA5 (1.00) KCNA5KCNH2KMT2ATSHRSMN1; SMN2
SCHEMBL2063205 0.67 KCNA5 (0.66) KCNA5KCNH2KMT2AMEN1ALDH1A1
SCHEMBL884297 0.65 KCNA5 (0.67) KCNA5KCNH2KMT2ASUCNR1ADRB1
SCHEMBL884739 0.65 KCNA5 (0.78) KCNA5KCNH2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT KCNA5 3796/4885KCNH2 4341/4885KMT2A 1440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback